[go: up one dir, main page]

AU6458898A - Compositions and use of m-csf-alpha - Google Patents

Compositions and use of m-csf-alpha

Info

Publication number
AU6458898A
AU6458898A AU64588/98A AU6458898A AU6458898A AU 6458898 A AU6458898 A AU 6458898A AU 64588/98 A AU64588/98 A AU 64588/98A AU 6458898 A AU6458898 A AU 6458898A AU 6458898 A AU6458898 A AU 6458898A
Authority
AU
Australia
Prior art keywords
csf
alpha
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64588/98A
Other languages
English (en)
Inventor
Varavani Dwarki
Kirston E. Koths
William C. Manning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU6458898A publication Critical patent/AU6458898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU64588/98A 1997-03-04 1998-03-04 Compositions and use of m-csf-alpha Abandoned AU6458898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3858397P 1997-03-04 1997-03-04
US60038583 1997-03-04
PCT/US1998/004802 WO1998039449A1 (fr) 1997-03-04 1998-03-04 COMPOSITIONS ET UTILISATIONS DE M-CSF-alpha

Publications (1)

Publication Number Publication Date
AU6458898A true AU6458898A (en) 1998-09-22

Family

ID=21900741

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64588/98A Abandoned AU6458898A (en) 1997-03-04 1998-03-04 Compositions and use of m-csf-alpha

Country Status (4)

Country Link
EP (1) EP0973904A1 (fr)
JP (1) JP2001517079A (fr)
AU (1) AU6458898A (fr)
WO (1) WO1998039449A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070447A2 (fr) * 2004-01-21 2005-08-04 Chiron Corporation Muteines de facteur de stimulation de colonies de macrophages (m-csf) et leurs utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002746A1 (fr) * 1987-09-22 1989-04-06 Cetus Corporation Utilisations du facteur-1 recombinant de stimulation de colonie
US6277368B1 (en) * 1996-07-25 2001-08-21 The Regents Of The University Of California Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine

Also Published As

Publication number Publication date
WO1998039449A1 (fr) 1998-09-11
JP2001517079A (ja) 2001-10-02
EP0973904A1 (fr) 2000-01-26

Similar Documents

Publication Publication Date Title
AU4842097A (en) Cementitious compositions and their uses
AU5699799A (en) Makeup compositions and methods of making same
AU5935398A (en) Detergent cosmetic compositions and use thereof
AU4266596A (en) Composition and use
AU2972597A (en) Compositions and uses thereof
AU6793898A (en) Asphalt compositions and methods of preparation thereof
GB9717598D0 (en) Novel composition and use
AU9166298A (en) Detergent cosmetic compositions and use
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU6726498A (en) Azeotropic or pseudoazeotropic compositions and use of these compositions
AU3730497A (en) Compositions and articles of manufacture
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU2003204844A1 (en) Use of methylnaltrexone and related compounds
AU1522400A (en) Substituted pyrimidine compositions and methods of use
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU5456898A (en) Compositions and articles of manufacture
AUPO982097A0 (en) Methods and compositions for use therein
AU7681498A (en) Pharmaceutical composition and use thereof
AU6682498A (en) Phagocytosis activator compositions and their use
AU5935298A (en) Detergent cosmetic compositions and use thereof
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU2221400A (en) Compositions containing and methods of using n-acyl-1h-aminoindenes
GB9718636D0 (en) Novel composition and use
AU8102498A (en) Preparation of diaryl-benzopyrans
AU691690B2 (en) Acrolein-releasing composition and use thereof